£114.71

This is the most expensive it has ever been. Walk away.

£115 today · previous high £115 · all-time low £108

Springer Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£114.71 £107.34 £108.95 £110.56 £112.16 £113.77 £115.38 22 August 2026 06 September 2026 21 September 2026 06 October 2026 22 October 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 2 price levels

Days at Price
Current Price
31 days 31 days · current 0 8 16 23 31 £108 £115 Days at Price

Price Analysis

Most common price: £108 (31 days, 50.0%)

Price range: £108 - £115

Price levels: 2 different prices over 62 days

Description

This volume gives the latest developments in on the mechanisms of cancer cell resistance to apoptotic stimuli, which eventually result in cancer progression and metastasis. One of the main challenges in cancer research is to develop new therapies to combat resistant tumors. The development of new effective therapies will be dependent on delineating the biochemical, molecular, and genetic mechanisms that regulate tumor cell resistance to cytotoxic drug-induced apoptosis. These mechanisms should reveal gene products that directly regulate resistance in order to develop new drugs that target these resistance factors and such new drugs may either be selective or common to various cancers. If successful, new drugs may not be toxic and may be used effectively in combination with subtoxic conventional drugs to achieve synergy and to reverse tumor cell resistance. The research developments presented in this book can be translated to produce better clinical responses to resistant tumors.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)
87% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Elsevier

£153.99 22 Oct 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
86% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 22 Oct 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
84% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£75.96 24 Oct 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
83% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£75.96 26 Oct 2026
Molecular Targeted Therapy of Lung Cancer
83% match

Molecular Targeted Therapy of Lung Cancer

Springer

£114.71 27 Oct 2026
Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)
83% match

Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)

Springer

£76.42 26 Oct 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
83% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.97 24 Oct 2026
Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)
83% match

Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£129.99 23 Oct 2026
Molecular Targets and Strategies in Cancer Prevention
83% match

Molecular Targets and Strategies in Cancer Prevention

Springer

£107.70 22 Oct 2026
Pharmaceutical Perspectives of Cancer Therapeutics
82% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 27 Oct 2026
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15
82% match

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15

Springer

£129.99 23 Oct 2026
Nutraceuticals and Cancer
82% match

Nutraceuticals and Cancer

Springer

£113.76 23 Oct 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
82% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 22 Oct 2026
Targeted Therapies for Lung Cancer (Current Cancer Research)
82% match

Targeted Therapies for Lung Cancer (Current Cancer Research)

Springer

£92.22 23 Oct 2026
Cell Signaling & Molecular Targets in Cancer
81% match

Cell Signaling & Molecular Targets in Cancer

Springer

£109.62 20 Oct 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
81% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£110.46 27 Oct 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
81% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£113.76 22 Oct 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
81% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Elsevier

£135.76 22 Oct 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
81% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£112.59 28 Oct 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
81% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.11 24 Oct 2026
Cancer Drug Design and Discovery
81% match

Cancer Drug Design and Discovery

Academic Press

£84.99 24 Oct 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
81% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.69 24 Oct 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
81% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£75.55 22 Oct 2026
81% match

Theranostic Approaches in Nuclear Medicine as a Strategy to Overcome Cancer Treatment Resistance (Novel approaches to overcome cancer resistance to conventional therapies)

Elsevier

£137.99 21 Oct 2026